As­cendis aims to raise $300M; Basilea inks up to $268M deal with BAR­DA

Plus, news about GSK, No­vo Nordisk, Tanai Ther­a­peu­tics, Nom­ic Bio, Brenus Phar­ma, Xspray, Achilles Ther­a­peu­tics, BioX­cel Ther­a­peu­tics and Nu­va­lent:

As­cendis’ $300M of­fer­ing: The Dan­ish com­pa­ny …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER